MATTES GLENN R. (President and CEO) sold 81.1% of their position (43K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $751.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/20/2021ACC: 0001213900-21-003298
DirectorOfficer· President and CEO
Since Oct 2019
-43K
Net shares
Net seller
$751.4K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
40K acquired · 83K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−3K
Price / share
$17.00
Trade value
$51K
% of position
30.0%
9/25/2020
10K→7K
Common Stock
Direct
Shares
+40K
Price / share
$2.50
Trade value
$100K
% of position
400.0%
1/15/2021
10K→50K
Common Stock
Direct
Shares
−40K
Price / share
$17.51
Trade value
$700.40K
% of position
80.0%
1/15/2021
50K→10K
Total
Net shares
−3K
Net value
-$651.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/25/2020 | S · Sale | −3K | $17.00 | $51K | 30.0% | 10K | 7K |
| Common Stock Direct | 1/15/2021 | M · Option Exercise | +40K | $2.50 | $100K | 400.0% | 10K | 50K |
| Common Stock Direct | 1/15/2021 | S · Sale | −40K | $17.51 | $700.40K | 80.0% | 50K | 10K |
| Total | −3K | -$651.40K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
40K shares
Shares
−40K
Strike price
2.5
Held after
1.03M
Exercisable
—
1/15/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock40K shares | 1/15/2021 | M · Option Exercise | −40K | 2.5 | — | 1.03M |